JBF Capital’s MacroGenics MGNX Stock Holding History

JBF Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-50,000	Closed	-$1.09M	–	69
2014 Q2	$1.09M	Buy	+50,000	New	+$1.05M	0.16%	33

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

PCA

Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return

JBF Capital's MGNX Position: Q3 2014 in Review

JBF Capital sold out of MacroGenics (MGNX) in Q3 2014, closing a stake of 50,000 shares — an estimated $1.09M sold.

JBF Capital first reported a position in MGNX in Q2 2014 and held it in 1 quarter. The position peaked at $1.09M in Q2 2014. 85 funds tracked by Wall St. Rank hold MGNX as of Q3 2014.

JBF Capital reported no remaining MacroGenics position as of Q3 2014 after selling out during the quarter.
JBF Capital sold 50,000 MacroGenics shares in Q3 2014, an estimated $1.09M.
JBF Capital first reported a position in MacroGenics in Q2 2014 and held it in 1 quarter.
JBF Capital's MacroGenics position peaked at $1.09M in Q2 2014.
85 funds tracked by Wall St. Rank held MacroGenics as of Q3 2014.

Based on JBF Capital's 13F filing for Q3 2014, filed 16 Oct 2014.